Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 6.17Laxmi Organic Industries Ltd, operating in the Chemical & Petrochemicals sector, demonstrates a mixed financial performance. The company shows strengths in solvency, growth, coverage, and profitability, suggesting a solid foundation and potential for expansion. However, liquidity and efficiency pose challenges, indicating potential difficulties in meeting short-term obligations and optimizing asset utilization. Financial ratios also reflect some areas of concern, particularly related to earnings per share and dividend distribution. While the company exhibits good revenue and operating profit growth, inconsistencies in net income and EPS growth need attention. Overall, Laxmi Organic Industries presents a blend of robust growth prospects and areas needing strategic improvement to ensure sustained financial health.
Health Score : 6.17Laxmi Organic Industries Ltd, operating in the Chemical & Petrochemicals sector, demonstrates a mixed financial performance. The company shows strengths in solvency, growth, coverage, and profitability, suggesting a solid foundation and potential for expansion. However, liquidity and efficiency pose challenges, indicating potential difficulties in meeting short-term obligations and optimizing asset utilization. Financial ratios also reflect some areas of concern, particularly related to earnings per share and dividend distribution. While the company exhibits good revenue and operating profit growth, inconsistencies in net income and EPS growth need attention. Overall, Laxmi Organic Industries presents a blend of robust growth prospects and areas needing strategic improvement to ensure sustained financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
57.66
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
57.66
P/B RATIO
2.30
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
1.61
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
0.00
EV/EBITDA RATIO
26.87
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹164.9 as on Sep 1, 2026.
Growth Score : 6.00The company demonstrates mixed growth performance. Strong revenue and operating profit growth rates are offset by declines in EPS and net income. While asset growth is robust, the inconsistencies in earnings growth suggest potential challenges in translating revenue into profits. Addressing these issues will be crucial for maintaining investor confidence and sustaining long-term growth.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 74.43 | -9.31 | 2.43 | 4.19 | -4.62 |
| Operating Profit Growth Rate | 68.64 | -33.15 | 3.23 | 11.72 | -40.21 |
| Earnings Per Share (EPS) Growth | 101.66 | -51.65 | -7.02 | -6.18 | -30.24 |
| Asset Growth Rate | 23.23 | 6.49 | 17.21 | 7.71 | 13.17 |
| Net Income Growth Rate | 101.57 | -51.17 | -3.2 | -5.79 | -30.7 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Rossari Biotech Ltd | 8.46 | 17.69 | Neutral | 286.00 | 25.79 | 149.00 |
| 2 | Fineotex Chemical Ltd | 8.39 | 52.51 | Neutral | 135.00 | 0.79 | 125.00 |
| 3 | Epigral Ltd | 8.26 | 16.11 | Undervalued | 566.00 | 77.19 | 332.00 |
| 4 | Bhansali Engineering Polymers Ltd | 8.25 | 17.56 | Undervalued | 216.00 | 7.25 | 180.00 |
| 5 | Galaxy Surfactants Ltd | 8.17 | 29.56 | Undervalued | 475.00 | 42.88 | 267.00 |
| 6 | Styrenix Performance Materials Ltd | 8.12 | 19.35 | Neutral | 463.00 | 180.10 | 273.00 |
| 7 | Balaji Amines Ltd | 7.71 | 46.70 | Overvalued | 265.00 | 51.09 | 169.00 |
| 8 | Tatva Chintan Pharma Chem Ltd | 7.13 | 89.27 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 9 | Neogen Chemicals Ltd | 6.69 | 197.61 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 10 | Laxmi Organic Industries Ltd | 6.17 | 57.66 | Neutral | 171.00 | 2.86 | 79.00 |
| 11 | Camlin Fine Sciences Ltd | 5.80 | 70.93 | Neutral | 107.00 | -1.72 | 24.00 |
| 12 | NOCIL Ltd | 5.27 | 50.94 | Neutral | 101.00 | 3.84 | 56.00 |
| 13 | Chemplast Sanmar Ltd | 4.81 | -9.62 | Neutral | 198.00 | -63.46 | -280.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤4th Feb 26
Q3 & 9M FY26 Earnings Conference Call
NEUTRAL SENTIMENT
No Stock News Available at This Moment.
Laxmi Organic Industries Ltd is a leading specialty chemical manufacturer in India, primarily focusing on Acetyl Intermediates and Diketene Derivatives. It holds a significant market position in ethyl acetate and various diketene-based products, catering to diverse industries like pharmaceuticals, agrochemicals, pigments, and printing & packaging.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Laxmi Organic Industries Ltd's P/E ratio (TTM) is 57.66, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Laxmi Organic Industries Ltd's P/B ratio is 2.30, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Laxmi Organic Industries Ltd's P/S ratio is 1.61, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Laxmi Organic Industries Ltd's PEG ratio is 1.10.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Laxmi Organic Industries Ltd's EV/EBITDA ratio is 26.87.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Laxmi Organic Industries Ltd's ROE is 3.98%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Laxmi Organic Industries Ltd's ROA is 4.96%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Laxmi Organic Industries Ltd's ROCE is 5%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Laxmi Organic Industries Ltd's operating margin is 6.01%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Laxmi Organic Industries Ltd's net margin is 2.77%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Laxmi Organic Industries Ltd's current ratio is 1.32.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Laxmi Organic Industries Ltd's debt-to-equity ratio is 0.25.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Laxmi Organic Industries Ltd's interest coverage ratio is 5.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Laxmi Organic Industries Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Laxmi Organic Industries Ltd's EPS is -30.24.
(Source line: "Ratios as of 08 Oct 2026, based on last traded price of ₹164.90. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1989
Headquarters: Mumbai, Maharashtra
Core Offerings: Ethyl Acetate, Acetic Anhydride, Diketene Derivatives, Specialty Esters, Amides & Arylamides
Stock Listing: NSE (LXCHEM), BSE (543277)
Promoter: Goenka Family / Laxmi Organic Group
Incorporated in 1989, Laxmi Organic Industries Ltd commenced manufacturing Ethyl Acetate in 1992 at its first facility in Mahad, Maharashtra. The company significantly expanded its product portfolio by venturing into Diketene derivatives in 2010. A major milestone was its successful Initial Public Offering (IPO) in 2021, which facilitated further growth and capacity expansion.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Acetyl Intermediates | ~50-55% | Operating Profit |
| Diketene Derivatives | ~40-45% | Operating Profit |
| Specialty Intermediates & Others | ~5-10% | Operating Profit |
Acetyl Intermediates: Primarily comprises Ethyl Acetate, a versatile bulk solvent and intermediate, and Acetic Anhydride, used in pharmaceuticals and textiles. This segment contributes a significant portion of the company's revenue.
Diketene Derivatives: Includes a wide range of value-added products like Esters, Amides, and Arylamides. These high-performance chemicals serve critical applications in pharmaceuticals, agrochemicals, pigments, and dyes industries, generally having higher margins.
Specialty Intermediates: Focuses on custom manufacturing of fine chemicals for niche applications and specific customer requirements, leveraging strong R&D capabilities.
Ravi Goenka: Chairman & Managing Director. As the founder, he has been instrumental in shaping the company's vision and strategic direction. Prakash G. Kabra: CEO & Whole-time Director. He brings extensive operational and technical expertise in the chemical industry, overseeing daily operations and growth initiatives.
Initial Public Offering (IPO) in 2021. No major recent bonus/rights issues or significant M&A on record.
The Laxmi Organic Industries Ltd share price today is ₹164.90 on NSE (LXCHEM), as of 08 Oct 2026.
As of 08 Oct 2026, Laxmi Organic Industries Ltd share price is ₹164.90, with previous close ₹164.90. Today's range is ₹164.90 to ₹164.90. The 52-week range is ₹N/A to ₹N/A.
As of today, Laxmi Organic Industries Ltd's market cap is ₹4,590.82 crore (Small Cap).
Laxmi Organic Industries Ltd's current P/E ratio is 57.66, compared to the CHEMICALS & PETROCHEMICALS sector average of 27.80.
Laxmi Organic Industries Ltd's current P/B ratio is 2.30.
Laxmi Organic Industries Ltd's current dividend yield is N/A. Last dividend of ₹0.50 per share was declared on 19-Sep-2023.
Laxmi Organic Industries Ltd's EPS (TTM) is ₹-30.24.
Laxmi Organic Industries Ltd is a leading specialty chemical manufacturer in India, primarily focusing on Acetyl Intermediates and Diketene Derivatives. It holds a significant market position in ethyl acetate and various diketene-based products, catering to diverse industries like pharmaceuticals, agrochemicals, pigments, and printing & packaging.
Laxmi Organic Industries Ltd is promoted by Goenka Family / Laxmi Organic Group, holding 69.35% as of 08 Oct 2026.
Laxmi Organic Industries Ltd is listed on NSE (LXCHEM) and BSE (543277). Its next quarterly results are expected on Mid-August 2024 (Q1 FY25).